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Abstract
The aim of the chapter is to provide a brief overview of diabetes and the associ-
ated morbidities that affect life expectancy to highlight why proactively planning 
for palliative and end-of-life care is essential to quality personalized diabetes care. 
Life expectancy may not be significantly reduced if blood glucose, lipids and blood 
pressure are well controlled; but several diabetes-related complications and long 
duration of diabetes affect life expectancy. Significantly, complications and related 
organ and tissue damage can be present 10–15 years before type 2 diabetes is diag-
nosed. The challenge of prognostication is discussed as recommendations for when 
to consider changing the focus of care from preventing diabetes complications to 
palliation and comfort care. Life-limiting illness and palliative and end-of-life care 
are defined. A framework for integrating diabetes and palliative care is proposed. 
The framework could help clinicians and people with diabetes prevent/manage 
complications and plan care to maintain quality of life, dignity and autonomy and 
ameliorate suffering as their life trajectory changes. The framework aims to facili-
tate care transitions and help clinicians proactively initiate management and have 
timely meaningful conversations about palliative and end-of-life care with older 
people with diabetes and their families.
Keywords: diabetes, complications, comorbidity, life-limiting illness, palliative,  
end of life, diabetes palliative care framework
1. Introduction
Diabetes is the most common chronic disease. People are at risk of diabetes 
due to genetic inheritance, epigenetic factors, age and lifestyle-related factors. The 
International Diabetes Federation (IDF) [1] estimated 123 million people aged 65–99 
had diagnosed diabetes and predicted the number would increase to 438 million by 
2045. Most older people have type 2 diabetes (T2DM), but people with type 1 diabetes 
(T1D) survive to older age. These data do not take account of the people with prediabe-
tes who may already have one or more life-limiting diabetes complications at diagnosis.
An estimated ~ 20 million people globally need palliative care the year before 
they die; a further 20 million need end-of-life care per year [2]. The World Health 
Organization (WHO) estimated that 71% of deaths in 2016 were associated 
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with diabetes complications. Most (~67%) occur in people aged 60 and older 
[3]. Therefore, older people with diabetes may have more than one life-limiting 
condition.
Aging is associated with reduced insulin production and insulin sensitivity that 
lead to insulin resistance, which increases by 1–2% per year [4]. Older age is generally 
defined as older than age 65 [5]. However, chronological age is not a good guide to dis-
ease, functional status, care needs or life expectancy. Biological age is a more accurate 
indicator of the rate at which body cells deteriorate but is more difficult to measure. 
Significantly, the individual’s chronological and biological age may be different [5].
Many older people have several coexisting comorbidities/geriatric syndromes, 
including cardiovascular disease, renal disease, sensory impairments, lower limb 
pathology, cognitive changes/dementia, some forms of cancer and frailty that indi-
vidually and collectively affect life expectancy [6–9]. Frailty predicts admission to a 
care home and mortality and increases the risk of death [10, 11]. Frailty is assessed 
in various ways, including phenotype and accumulation of deficits. The latter may 
be more useful to prognostication.
Many older people with diabetes have at least three coexisting comorbidities, 
but these are often managed as single entities that may not address the many diffuse 
symptoms [12–14] or the need to change the focus of care from achieving nor-
moglycaemia to prevent complications to focus on comfort by managing existing 
complications and preventing hypoglycaemia and hyperglycaemia.
People with diabetes who can maintain near-normal glycaemia (~7%) and 
normal lipids and blood pressure are less likely to develop complications and may 
not have significantly reduced life expectancy. However, these parameters are 
often abnormal some 10–15 years before type 2 diabetes (T2DM) is diagnosed, 
and complications can be present and affect life expectancy from diagnosis [7, 12]. 
In addition, older people are less likely to benefit and more likely to be harmed by 
‘tight blood glucose control’. Therefore, blood glucose and HbA1c target ranges need 
to be individualized to minimize risk, especially hypoglycaemia risk and other risk 
factors being managed [15, 16].
Diabetes and the associated comorbidities affect the quality of life, compromise 
function and self-care and increase the need for hospital admissions and readmis-
sions and eventually lead to death [11, 13, 17]. Over 50% of people aged 65–80 
experience moderate to severe disability and increased dependency. On average, 
they need care 24 hours/day between 1.3 and 6.9 years [18].
Significantly, older people with diabetes and concomitant heart failure who 
have several recent hospital admissions and consult multiple prescribers are at risk 
of readmission within 30 days [19]. Hospital admissions near the end of life often 
result in burdensome and futile treatment that causes significant suffering and 
stress for the individual and their family [19, 20]. Likewise, people with cognitive 
impairment face many challenges, including decisions about their care.
Thus, starting conversations about the likely prognosis early in the disease 
trajectory can enhance people’s capacity to make meaningful decisions and enable 
them to document their values and care preferences [21, 22]. In turn, clearly 
documented values and care preferences enhance family and health  professionals’ 
capacity to make care decisions consistent with the person’s values and reduce 
decisional uncertainty.
2. Diabetes care
Quality diabetes care is described in many clinical guidelines such as the IDF 
[7], American Association of Diabetes/European Association for the Study of 
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Diabetes [23], Australian Diabetes Society [24] and Diabetes UK [25]. Many 
recommend ‘relaxing’ glycaemic targets in older people to reduce the risk of 
hypoglycaemia and its consequences: they usually do not include comprehensive 
guidance about other key aspects of palliative and end-of-life care. Exceptions 
are the IDF Global Guideline for Managing Older People with T2DM [7] and 
Guidelines for Managing Diabetes at the End of Life (currently under review) [8] 
and Diabetes UK [26].
Quality diabetes care encompasses achieving normoglycaemia (HbA1c 
<6.5 7%), controlling blood lipids and blood pressure using diet and exercise 
and commencing glucose-lowering (GLM), lipid-lowering and antihyperten-
sive agents and other medicines when indicated, providing diabetes self-care 
 education and undertaking regular health assessments. Self-care and adherence 
to recommendations are important to maintain health and meet metabolic 
targets.
Assessments could also encompass determining when the individual could 
benefit from palliative care and when to document an end-of-life care plan and an 
advance care directive (ACD). However, many clinicians find it difficult to discuss 
death and dying (giving bad news). Consequently, they miss opportunities to initi-
ate conversations about these issues, and beneficial palliative care can be delayed 
[20, 21, 27]. Death cannot be cured: people’s end-of-life can be made comfortable, 
dignified and consistent with their values and care preferences when these are 
known, clearly documented and communicated.
Many clinicians regard death and dying as treatment failure [28]. The terms ‘fail-
ure’ and ‘bad news’ are inherently negative. People often know they are not going 
to recover and want affirmation from their health professionals [28]. Some people 
express the wish to die while their identity and personhood can be maintained 
and not when they are terminally ill and incapable of making rational thoughts 
and informed decisions [29]. When such discussion does occur, health profes-
sionals often present the options as a choice between continuing and withdrawing 
treatment.
3. Palliative care
Palliative care originated in the 1960s and largely focused on end-of-life care at 
that time. More recently, there is increasing recognition that people with chronic 
disease could benefit from palliative care; thus the term broadened in meaning and 
scope to include non-communicable chronic diseases [30]. Most adults with chronic 
disease need palliative care as a result of cardiovascular disease [9, 11]. Diabetes is 
the leading cause of cardiovascular disease, and, in turn, cardiovascular disease is 
the leading underlying cause of diabetes-related deaths [3, 6, 31]. All health profes-
sionals who care for people with diabetes have a role in timely implementation 
of palliative care. Therefore, health services need to integrate such care into the 
services they offer and policies [32].
The patterns of dying are changing as more people follow the chronic disease 
trajectory, which is characterized by periods of deterioration followed by recovery 
until physiological reserves are depleted and the person reaches the terminal and 
end-of-life stages [32–34]. Many experts recommend palliative care should be 
implemented early in the disease trajectory, sometimes from diagnosis, for greatest 
benefit [30, 32]. In fact, Murray et al. recommend ‘[clinicians] should routinely and 
systematically consider whether our patients might benefit from early palliative 
care’ [34]. Table 1 explains the terms palliative care, life-limiting illness, end-of-life 
care and advance care planning.
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Term Explanation Considerations
Life-limiting 
illness
The term life-limiting illness (LLI) describes 
people at high risk of dying in the subsequent 
12 months. Many people admitted to hospitals 
and ICUs have a life-limiting illness. The Gold 
Standards Framework Proactive Indicator [33] 
outlines indicators of life-limiting illnesses 
for cancer, chronic obstructive pulmonary 
disease, heart failure, renal disease, neurological 
diseases, frailty, dementia and stroke
Diabetes is not specifically mentioned in the 
GSF. It does mention organ failure, kidney 
disease, dementia and multimorbidity. Diabetes 
is the main underlying cause of renal disease, 
cardiovascular disease and some forms of 
cancer, frailty and dementia. Therefore, it is 
often unclear what ‘initial’ disease commenced 
the underlying pathological changes, which 
could be an inflammatory process related to 
obesity
Diabetes experts recommend normalizing 
blood glucose, lipids and blood pressure to 
reduce the risk of complications that can 
reduce life expectancy
Palliative care experts and many geriatricians 
recommend people to document their values 
and end-of-life preferences while they 
are able to make informed, autonomous 
decisions
Fewer than 50% of people with life-limiting 
illnesses actually have documented goals of 
care, and < 24% has documented care  
goals [36]
Palliative care The aim of palliative care is to improve the 
quality of life, relieve suffering and manage 
distressing symptoms
Palliative care involves symptom management, 
prognostication, advance care planning and 
transition to the dying/terminal stage [36]
Palliative care can be used at any time and can 
complement usual diabetes care. Palliative care 
should be commenced early for maximum 
benefit to archive these aims [3, 31]. Early 
palliative care also increases satisfaction with 
care [34]
Many older people with diabetes could benefit 
from combining palliative care into their 
usual diabetes care as function changes and 
the burden of medicines and complications 
increase
They also benefit from the support to 
document advance care directives much earlier 
than it currently occurs [36, 37]
Good communication is essential to support 
older people to make informed decisions and 
to document their values and care preferences 
and goals
End-of-life 
care
The last 12 months of life and includes imminent 
death in a few hours or days [2, 30, 33]
Four phases are described: stable, unstable, 
deteriorating, terminal [38]
Many people want to die at home, but most 
older people with multiple comorbidities die in 
hospital [39]
Recognize/diagnose dying
Identify whether unstable disease is likely to be 
remediable or likely to continue to deteriorate 
and progress to the terminal stage
Treat or implement end-of-life care
Advance care 
directive 
(ACD)
Advance care planning (ACP) is the process 
used to develop and ACD
ACD is a document that clearly describes an 
individual’s values and the type of treatment 
they want if they are not capable of deciding for 
themselves and guides their medical treatment 
decision-maker and clinicians to make decision 
on their behalf that accord with their values and 
care preference [40]
ACDs are often first documented when the 
individual has a rapid response team (RRT) call 
to assess sudden deterioration [41, 42]
It is important to consider cultural and religious 
conventions when discussing ACDs. These 
differ among cultures and within cultures and 
influence laws and regulations and the way 
individual’s view end of life and ACDs
Important information for older people 
with diabetes to document in their ACD are 
the things they value and give meaning and 
purpose to their life (values directive), the care 
they want to receive and the care they do not 
want to receive [40]. Generally the ACD does 
not have to be completed all at once. Older 
people need time to think about the issue and 
discuss them with relevant people. So, start the 
conversation and follow up at a later time
It is important to check the persons’ care 
preferences as part of ongoing care because 
they can change over time. Values remain 
relatively constant
Table 1. 
Explanation of the terms life-limiting illness, palliative care, end-of-life care and advance care directives.
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4.  Diagnostic uncertainty and prognostic challenges: Challenges to 
discussing palliative and end-of-life care
It is certain that everybody will die eventually. The uncertainty lies in when and 
how an individual will die. The trajectory to death for people with diabetes can 
be a long and healthy one but is often a long process of physical and social decline 
followed by recovery until the final stages of life: the so-called chronic disease 
trajectory [2, 43, 44]. People can die, seemingly suddenly, during a disease exacer-
bation. However, most of these people have one or more indicators of limited life 
expectancy. Thus, their death was possibly predictable: the time of death might not 
have been. Episodes of deterioration become increasingly frequent over time and 
reduce the remaining physiological reserve and the person’s ability to recover from 
subsequent exacerbations.
The chronic disease trajectory to end of life is unpredictable and includes many 
periods of deterioration and recovery before death occurs [38, 43, 44], which cre-
ates a degree of diagnostic uncertainty for many health professionals, people with 
diabetes and families. The uncertainty is compounded by challenges associated with 
prognostication and, sometimes, from misinterpreting individual’s questions such 
as ‘how long have I got Doc?’ Mostly the individual wants an idea about how long 
they have left ‘to put their house in order’ and ‘say my goodbyes’. Such questions 
could be a cue to health professionals to begin advance care planning to document 
the individual’s values and care goals and preferences. Some strategies to enhance 
such conversations are shown in Table 2.
Diagnostic uncertainty encompasses cognitive, emotional and ethical reac-
tions, which are affected by the need to discuss care options with the individual 
• Use a value-based approach rather than focusing on medical decisions
• Conversations can be planned or opportunistic
• If planned ask the individual who they would like to be present during the conversation and have all 
relevant information and documents ready
• Ensure the environment is confidential and welcoming
• Ensure the person brings any communication aids they need with them, e.g. spectacles and hearing aids
• Present the information in easy-to-understand words and formats, and assess their understanding
• Frame the conversation as part of the individual’s life story. Use own knowledge of life expectancy in 
similar conditions
• Recognize and respond to verbal, non-verbal and emotional cues appropriately
Some useful questions include the following: these questions should not be used as a ‘tick box’ list. They must 
be personalized to the individual and the situation. The questions need not be asked in any particular order
• What do I need to know about you to help me give you the best possible care and advice?
• What things make your life worth living or matter to you? Rather than asking about the quality of life.
• What does suffering mean to you?
• What does a good death mean to you?
Not interrupting the individual is a key skill
Older people need time to process the question in order to respond—a complex cognitive process, especially 
when the topic is emotive. Interrupting can cause confusion and change the discussion, and important issues 
might not be identified
Understand and accept that not everybody is capable of making informed decisions during a crisis and some 
people prefer certainty, i.e. to be ‘told what to do’
Table 2. 
Strategies to enhance conversations about palliative and end-of-life care among older people with diabetes, 
families and clinicians [40, 49, 64, 65].
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and often their families as well as organizational culture and personal experience 
[31] and individual tolerance of uncertainty [45]. Some degree of uncertainty 
occurs in nearly every aspect of health care and influence clinician and patient 
outcomes. Types of uncertainty include disease, therapeutic (risk and benefit) 
and prognosis [46].
Informed shared decision-making requires the individual to understand their 
illness, their treatment options and prognosis. Clinicians may not be comfortable 
disclosing their uncertainty to the individual [22, 46] and may refer them for a sec-
ond opinion, admit them to hospital and/or order a barrage of diagnostic investiga-
tions [47]. These actions may or may not be indicated/warranted.
Sudden, unexpected death occurs in ~ 25% of deaths [2, 20]; however, 
diabetes-related deaths are often multifactorial, which makes it more difficult 
to predict life expectancy. A number of changes and well-defined patterns 
accompany functional decline to the end of life. These patterns are described in 
a series of disease trajectories [43, 44]. Prognostic indicators, include the Gold 
Standards Framework Proactive Identification Guidance (PIG) [35], life expec-
tancy and risk calculators, the Diabetes Complications Severity Index (DCSI) 
[47], Cardiovascular risk tools and life expectancy calculators. These tools and 
calculators can help health professionals tailor care with the individual and start 
conversations about advance care planning.
Some experts recommend using absolute risk to decide which people are most 
likely to benefit from treatment because it considers the whole person and their 
individual determinates of risk [48]. These tools do not predict death. They are a 
guide to self-care education and care planning.
General indicators described in the GSF that indicate palliative care could be 
beneficial include:
• Decline in health and function.
• Unplanned hospital admissions.
• Symptoms that are difficult to manage.
• The person becomes less responsive to treatment.
• Person chooses not to accept active treatment.
• > 10 Kg progressive weight loss in the preceding 6 months.
• Serum albumin <25 g/L—other guidance suggests <5% in people with 
sarcopenia.
• More than 50% have a significant life event such as a fall, admission to a care 
home or bereavement.
In addition, a range of diabetes-related factors associated with reduced life were 
identified in a targeted literature review [49–51] and include:
• Long duration of diabetes.
• Macro- and microvascular complications [49]. Diabetes significantly increases 
the risk of all-cause and cardiovascular mortality in men and women by two- 
to fourfold [50].
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• Glucose variability (fluctuation between high and low blood glucose levels) 
and rapid reduction in HbA1c [52–54].
• Multimorbidity: 80% of people 80 years and older have an average of 3.6 
morbidities [54, 55].
• Severe hypoglycaemia [56–58] especially in older people and those on sulpho-
nylureas or insulin and those with hypoglycaemic unawareness, including 
dementia.
• Lower limb and foot disease [59, 60].
• Polypharmacy [61].
• Cancer contributes to increased mortality in T2DM.
• Comorbid depression [62]: it is important to recognize and explore suicide 
ideation; suicide is twice as common in older people, and depressive symptoms 
are present in 80% of people > aged 74 who commit suicide. The severity of 
depression is a determinant of suicidal ideation [63].
This information and other prognostic indicators can be used independently or 
together to guide discussions with people with diabetes about advance care plan-
ning, their ACD and when to initiate palliative care. Documenting and ACD are part 
of holistic, evidence-based quality care.
4.1 Strategies that clinicians use to reduce prognostic uncertainty
Uncertainty occurs in all areas of health care, not just palliative and end-of-life 
care. A number of strategies can help clinicians reduce decisional uncertainty. These 
include:
• Acknowledging their uncertainty to themselves, colleagues, the individual and 
their family [46]. Not acknowledging uncertainty leads to further uncertainty 
and other problems. Acknowledging it can help build rapport and trust with 
the individual and their family.
• Accepting that death is normal and being able to recognize common disease pat-
terns and their consequences that compromise life expectancy, signs of deteriora-
tion and signs that death is approaching. Guidance concerning these issues is 
described in the GSF [33], Murtagh et al. [31] and a suite of three tailored versions 
of information for older people with diabetes, family carers and clinicians [64].
• Understanding that many people choose comfort and quality of life over a 
longer life.
• Being able to recognize deterioration beyond the clinical parameters used in acute 
care. For example, using the GSF, which recommends asking the ‘surprise ques-
tion’: ‘would I be surprised if this person died soon?’ The answer, yes or no, can 
guide treatment decisions, including whether and when to implement palliative 
care and aspects of usual diabetes care such as HbA1c, blood glucose monitoring 
and other metabolic parameters and when to initiate conversations about advance 
care planning with the individual older person and relevant others.
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• Developing communication skills and the confidence to discuss palliative and 
end-of-life care. These skills increase following communication skills training 
[65] and include asking ‘good/appropriate’ questions, listening to the answers and 
using relevant probing and clarifying questions when relevant; see Table 2.
• Understanding that ACP is an iterative process that can be achieved using 
structured ACP communication tools and processes.
• Consulting the individual’s ACD. ACDs are an outcome of advance care 
planning; they inform clinicians and families about the individual’s values 
and preferences and enable medical treatment decision-makers, family and 
clinicians to make decisions consistent with the person’s values when they are 
unable to decide for themselves [40, 64, 65].
• Asking about subjective life expectancy such as will to live is a strong predictor 
of survival in all age groups and genders [66, 67].
• Asking questions about self-rated future health, e.g. in 5 years, and adjusting 
for known mortality risk factors [67].
• Considering the health and care burden of informal/family carers: their subjec-
tive care burden is linked to various health outcomes for the care recipient 
including mortality risk [67, 68].
• Considering relevant policies, regulations and legislation that apply where the 
clinician works [51, 66].
These strategies show that subjective information and shared decision-making 
is an important part of the health assessment and risk calculations. After all, 
death is a very personal experience. They can help clinicians can include palliative 
and end-of-life care in usual diabetes clinical practice guidelines, is important.
4.2 Some key diabetes palliative care issues
Figure 1 depicts a framework for integrating diabetes and palliative and end-of-
life care based on function and the chronic disease trajectory. The information can 
be used as a basis for developing a personalized care plan and with usual diabetes 
and palliative care guidelines.
Commencing palliative care does not mean usual diabetes care is abandoned. 
All care must be based on the best evidence. Care must be personalized and, 
ideally, developed in consultation with the older individual and often their 
family carers. People with diabetes do receive ‘usual’ palliative care, but it may 
not encompass important diabetes-specific issues that need to be considered. 
Specific information about these issues can be found in Dunning et al. [8] and 
Diabetes UK [26].
4.3 Managing glycaemia
Preventing hyperglycaemia is important to prevent ketoacidosis and hyperosmo-
lar states, both of which cause considerable discomfort and can be fatal. Likewise, 
preventing hypoglycaemia is imperative. It is often missed because of the changed 
9Diabetes and Palliative Care: A Framework to Help Clinicians Proactively Plan...
DOI: http://dx.doi.org/10.5772/intechopen.83534
Figure 1. 
Proposed framework for integrating diabetes care with palliative care that supports function and proactive 
care planning. Reproduced from Dunning et al. [72] with permission. The framework has not been formally 
evaluated at this stage.
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symptomatology and can become chronic. Hypoglycaemia is a risk factor for frailty 
[69] and cardiovascular disease [70] and leads to short-term cognitive changes and 
dementia in the longer term.
T2DM is associated with brain aging and cognitive changes that affect memory 
and learning and contribute to depression in the longer term. Thus, blood glucose 
monitoring in a suitable regimen tailored to the medicine regimen and hypo-hyper-
glycaemia risk profile can provide important information about glucose variability, 
the medicine regimen and care needs.
4.4 Managing medicines: Pharmacovigilance
Pharmacovigilance is important and includes regular medicine reviews, stopping 
medicines and using non-medicine options where possible and selecting the lowest 
effective dose when medicines are indicated. Insulin might be a safer option than 
some other glucose-lowering medicines and can be used with a palliative intent, that 
is, to improve comfort by managing unpleasant symptoms associated with hypergly-
caemia. Some medicines are diabetogenic, and it is important to diagnose hypergly-
caemia caused by medicines such as glucocorticoids and manage it appropriately.
4.5 Nutrition and hydration
Undernutrition can contribute to frailty, hypoglycaemia, slow wound healing 
and falls and can be present in overweight individuals. Eating disorders, depres-
sion, difficulty swallowing and other causes can be present. Likewise cancer, 
thyroid disease and other diseases can cause weight changes. These factors 
highlight the value of comprehensive geriatric assessments and collaborative 
interdisciplinary care.
4.6 Family carers
Family carers play a vital role in the care of children and older people with 
diabetes by helping with diabetes self-care and other activities of daily living. They 
are at risk of sleep deprivation, reduced immunity, depression and unresolved 
bereavement after their relative dies [68]. It is important to monitor their health and 
provide counseling and support.
5. Summary
Long-standing diabetes and associated complications significantly increase the 
risk of disability and frailty and reduce life expectancy. Palliative care can be used 
with usual diabetes care. Proactively planning for diabetes palliative care is important. 
Diabetes reduces life expectancy and can cause significant suffering. Considering the 
indicators of reducing life expectancy and implementing palliative care early into the 
diabetes care plan has many benefits, including reducing the suffering and the burden 
on the individual and family carers. Atypical symptoms associated with older age can 
make it difficult to recognize deterioration and underlying causes.
People admitted to hospital near their end of life are more likely to receive bur-
densome treatment such as admission to intensive care, resuscitation, dialysis and 
blood transfusions that are often futile [45, 46] and distressing for the individual 
and their families. Health professionals have an important role in helping older 
people with diabetes to plan for predictable changes in health status and to initiate 
timely palliative and EOL care to prevent unnecessary admissions to hospital and/or 
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